When you pick up medication at the drugstore, intuitively you might think that the cost of the drug is what you’re paying for. But you are not merely paying for the R&D and manufacturing costs; there is a complex system of middlemen that hike up the price of virtually every drug in the US market.Continue Reading

Markets rallied after the Fed’s first rate cut of 2025, but fears of recession linger as yield curve signals danger. Trump’s $100,000 H-1B visa fee sparked global panic, Indian tech stocks slid, and a looming U.S. government shutdown threatens to shake confidence even further. Meanwhile, Boeing’s new F-47 fighter and defense tech expansion highlight shifting military priorities as global tensions intensify.Continue Reading

Authors: Faith Spalding, Lucy Cox Editors: Faith Spalding, Lucy Cox Intro:  Welcome to the Weekly BluRB, a newsletter catered to students and professionals seeking the latest news and insights on global markets. Get prepared for the week by reading four stories circulating around equity markets, macro trends, geopolitics and newContinue Reading